BLB&B Advisors, LLC
- SEC CIK
- 0001389059
- Latest filing
- Aug 5, 2026
ELTX holding history
Elicio Therapeutics, Inc. in every 13F filed by BLB&B Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ELTX overviewAll 13F holders of ELTXFull Q2 2026 holdings
- Shares (Q2 2023)
- 0
- Sold out in Q2 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2023 | 0 | $0 | 0.0% | −1,550−100.0% | Sold outConverted for a 1-for-10 split | Holders |
| Q1 2023 | 15,495 | $8.99K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 15,495 | $12.6K | <0.1% | −7,500−32.6% | Reduced | Holders |
| Q3 2022 | 22,995 | $21.0K | <0.1% | −33,852−59.5% | Reduced | Holders |
| Q2 2022 | 56,847 | $65.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 56,847 | $121.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 56,847 | $165.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 56,847 | $555.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 56,847 | $740.0K | 0.1% | +56,847 | New | Holders |